Research Solutions, Inc. (NASDAQ:RSSS – Get Free Report) saw a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 42,000 shares, a decrease of 62.9% from the February 13th total of 113,300 shares. Based on an average trading volume of 181,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.1% of the shares of the company are sold short.
Research Solutions Stock Performance
Shares of RSSS opened at $2.93 on Thursday. The company has a 50-day simple moving average of $3.59 and a 200-day simple moving average of $3.25. Research Solutions has a 52 week low of $2.38 and a 52 week high of $4.24. The firm has a market capitalization of $95.66 million, a P/E ratio of -19.53, a P/E/G ratio of 4.33 and a beta of 0.55.
Research Solutions (NASDAQ:RSSS – Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.09). The business had revenue of $11.91 million for the quarter, compared to analyst estimates of $11.86 million. Research Solutions had a negative net margin of 8.41% and a negative return on equity of 6.59%. As a group, equities analysts forecast that Research Solutions will post 0.05 earnings per share for the current year.
Institutional Trading of Research Solutions
About Research Solutions
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets.
Further Reading
- Five stocks we like better than Research Solutions
- NYSE Stocks Give Investors a Variety of Quality Options
- Gold Rally vs. Oil Surge: Where Investors Are Betting Next
- ESG Stocks, What Investors Should Know
- Intel Stock Surges on New CEO – The Real Story Runs Deeper
- Using the MarketBeat Stock Split Calculator
- Market Overreacts, But Guidewire’s Growth Story Remains Strong
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.